
New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.

New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.

Researchers stress that no conclusions can be drawn yet about the safety of cannabis and cannabinoid research.

ART treatment results in higher CD4+ T-cell frequency, lower cellular activation, and higher proportions of naive T-cells.

Researchers find mechanism that enables cells to migrate in a specific tissue.

Evidence shows demyelination and neuroaxonal abnormalities occur in both the white and grey matter of MS patients.

Eli Lilly and Company and Incyte Corporation have submitted a new drug application to the FDA for the approval of oral once-daily baricitinib for the treatment of moderate to severe rheumatoid arthritis.

Partisan split found in those who believe America should devote more funds to global health care initiatives.

Researchers find cancer evolves in specific patterns that are predictable through the laws of nature.

Genetic modifications enhance local DNA repair and protection in cancer treatment.

Some patients with amyotrophic lateral sclerosis who received the stem cell therapy showed less progression and improved respiratory and motor functions.

Hepatitis C treatment with pegylated interferon alpha may lead to anti-interferon antibodies.

High-intensity interval training found to increase ’ maximum oxygen uptake and improve the heart recovery rate in RA patients.

ACOs combined for a total net savings of $411 million in 2014.

Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.

Top news of the week in cancer drug development and research.

Estrogen found to reduce the ability of the immune system to attack the brain in MS patients.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Venetoclax is a B-cell lymphoma-2 protein inhibitor for the treatment of CLL patients who received a least one prior therapy.

Researchers explore digital health solutions for COPD symptom management.

Tumors that over-express a specific oncogene may benefit from combination therapy regardless of cancer type.

New research may transform oncology drug development.

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Use of exomes shield lung cancer drug from immune system defenses.

Top stories of the week on Specialty Pharmacy Times.

Patients with inflammatory rheumatic diseases may not need more frequent vaccinations.

Traditional cancer therapies like chemotherapy or radiation are not generally effective for colorectal cancer patients.

HCV treatment has been shown to cure up to 100% of patients depending on genotype and stage of liver disease.

Being overweight or obese associated with a decreased risk of subsequent RA diagnosis.

Acceptance is a multiple sclerosis treatment goal because it is associated with better drug adherence.

Carfilzomib approved in combination with dexamethasone, or with lenalidomide plus dexamethasone, for patients with relapsed/refractory multiple myeloma.